These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6197855)

  • 1. Clinical significance of beta-thromboglobulin in patients with high platelet count.
    Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Bonvicini P; Girolami A
    Acta Haematol; 1984; 71(1):32-8. PubMed ID: 6197855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal plasma concentrations of beta-thromboglobulin in chronic myelocytic leukemia and primary thrombocythemia.
    Endo Y; Mamiya S; Sato M; Takahashi K
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):699-701. PubMed ID: 92163
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
    Viero P; Cortelazzo S; Bassan R; Barbui T
    Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of beta-thromboglobulin and platelet factor-4 in polycythaemic patients.
    Najean Y; Poirier O; Lokiec F
    Scand J Haematol; 1983 Oct; 31(4):298-304. PubMed ID: 6194555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo platelet release in myeloproliferative disorders.
    Ireland H; Lane DA; Wolff S; Foadi M
    Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
    Viero P; Cortelazzo S; Barbui T
    Thromb Haemost; 1984 Jul; 51(3):411. PubMed ID: 6208631
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders.
    Wehmeier A; Fricke S; Scharf RE; Schneider W
    Eur J Haematol; 1990 Oct; 45(4):191-7. PubMed ID: 2146144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet alpha-granule release in chronic myeloproliferative disorders with thrombocytosis.
    Sacchi S; Curci G; Piccinini L; Messerotti A; Cucci F; Bursi R; Zaniol P; Torelli U
    Scand J Clin Lab Invest; 1986 Apr; 46(2):163-6. PubMed ID: 2424075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of beta TG/PF4 ratio in patients with high platelet count.
    Fabris F; Luzzatto G; Girolami A
    Thromb Haemost; 1985 Apr; 53(2):288-9. PubMed ID: 2410998
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of platelet life-span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets.
    Bautista AP; Buckler PW; Towler HM; Dawson AA; Bennett B
    Br J Haematol; 1984 Dec; 58(4):679-87. PubMed ID: 6240280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet and plasma beta thromboglobulin in myeloproliferative syndromes and secondary thrombocytosis.
    Boughton BJ; Allington MJ; King A
    Br J Haematol; 1978 Sep; 40(1):125-32. PubMed ID: 81681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
    Barbui T; Cortelazzo S; Viero P; Bassan R; Dini E; Semeraro N
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function in patients with high platelet counts.
    Ginsburg AD
    Ann Intern Med; 1975 Apr; 82(4):506-11. PubMed ID: 1054537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta-thromboglobulin (author's transl)].
    Endo Y
    Rinsho Byori; 1981 Jan; 29(1):20-5. PubMed ID: 6169853
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated plasma beta-thromboglobulin levels in multiple myeloma and in polycythaemia vera.
    Schernthaner G; Ludwig H; Silberbauer K
    Acta Haematol; 1979; 62(4):219-22. PubMed ID: 93844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a platelet membrane defect in the myeloproliferative syndromes.
    Castaldi PA; Berndt MC; Booth W; Gregory C; Bull H; Greaves M
    Thromb Res; 1982 Sep; 27(5):601-9. PubMed ID: 6960545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of beta-thromboglobulin and platelet factor 4 in relation to the venous platelet concentration.
    Kutti J; Safai-Kutti S; Zaroulis CG; Good RA
    Acta Haematol; 1980; 64(1):1-5. PubMed ID: 6158243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of platelet aggregation abnormalities in thrombocytosis after thrombocytopheresis.
    Fabris F; Belloni M; Casonato A; Randi M; Ongaro G; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):853-62. PubMed ID: 6176511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
    Schernthaner G; Silberbauer K; Mühlhauser I; Willvonseder R
    Acta Med Austriaca Suppl; 1979; 6():375-9. PubMed ID: 95543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activation in myeloproliferative disorders.
    Cortelazzo S; Viero P; Barbui T
    Thromb Haemost; 1981 Jun; 45(3):211-3. PubMed ID: 6169172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.